@oriro/orirocli 0.1.8 → 0.1.11

package/skills/health/health-skin/SKILL.md

@@ -1,71 +1,71 @@
----
-watermark: ORIRO
-disable-model-invocation: true
-name: health-skin
-provider: ORIRO.ai
-copyright: Copyright (c) 2026 ORIRO.ai
-description: >
-  Skin health and dermatology — skin care, common conditions, sun protection,
-  acne, eczema, psoriasis, and skin cancer prevention. Activate for questions
-  about skin care, rashes, acne, skin conditions, sun protection, or any
-  skin health question. Sources: AAD (American Academy of Dermatology), NIH.
----
-
-# Skin Health and Dermatology
-
-## Skin basics
-
-**Three layers:** Epidermis (outer, barrier), Dermis (collagen, blood vessels, hair follicles, glands), Subcutis/Hypodermis (fat, insulation).
-**Skin functions:** Barrier (infection, UV), temperature regulation, sensation, vitamin D synthesis.
-**Skin types:** Normal, dry, oily, combination, sensitive. Can change with age, climate, products.
-
-## Sun protection (most important anti-aging and cancer prevention)
-
-**UV radiation:** UVA (ages skin, penetrates glass) + UVB (burns, main cause of skin cancer).
-**SPF:** Measures UVB protection only. SPF 30 blocks 97%. SPF 50 blocks 98%. Diminishing returns above 50.
-**Broad spectrum:** Protects against both UVA and UVB. Required on the label.
-**Application:** 1 ounce (shot glass) for full body. Reapply every 2 hours in sun, after swimming/sweating.
-**Daily use:** On face even without direct sun exposure. UVA penetrates windows.
-**Melanoma:** Most dangerous skin cancer. ABCDEs: Asymmetry, Border irregularity, multiple Colors, Diameter > 6mm, Evolving. Any changing mole → dermatologist.
-
-## Common skin conditions
-
-### Acne
-
-**Pathophysiology:** Excess sebum + C. acnes bacteria + clogged pores + inflammation.
-**Treatment ladder:**
-Mild: Benzoyl peroxide (kills bacteria) or salicylic acid (exfoliates) — OTC.
-Moderate: Topical retinoids (tretinoin) + topical antibiotics — prescription.
-Severe: Oral antibiotics + topical retinoids, or isotretinoin (Accutane) for severe nodular/cystic.
-**Retinoids:** Most evidence for acne AND anti-aging. Start slowly (every other night), expect initial irritation. Results in 3-6 months.
-
-### Eczema (Atopic Dermatitis)
-
-Chronic inflammatory skin condition. Itchy, red, dry patches. Often begins in childhood.
-**Management:** Moisturize frequently (thick creams, not lotions). Avoid triggers (soaps, certain fabrics, temperature extremes). Topical corticosteroids for flares. Dupilumab (Dupixent) biologic for moderate-severe.
-
-### Psoriasis
-
-Autoimmune. Rapid skin cell turnover → thick plaques with silvery scales. Elbows, knees, scalp common.
-Can be associated with psoriatic arthritis.
-Treatment: Topical corticosteroids, vitamin D analogues, systemic biologics for severe (TNF inhibitors, IL-17, IL-23 inhibitors).
-
-## Skincare routine (evidence-based)
-
-**Morning:**
-
-1. Gentle cleanser (if needed — many people only need water in AM)
-2. Vitamin C serum (antioxidant, brightening)
-3. Moisturizer
-4. SPF 30+ broad spectrum
-
-**Evening:**
-
-1. Cleanser (double-cleanse if wore SPF)
-2. Retinol/retinoid (anti-aging, acne)
-3. Moisturizer
-
-**Don't need:** Most of what advertising says you need. Fewer products with proven ingredients beat elaborate routines with trendy ones.
-Proven ingredients: SPF (prevent), Retinoids (treat aging, acne), Vitamin C (antioxidant), Niacinamide (multiple benefits), Hyaluronic acid (hydration), Ceramides (barrier repair).
-
-Sources: AAD (aad.org — free patient education), Skincare by Hyram evidence-based content (free), r/SkincareAddiction wiki (community-curated free resource)
+---
+watermark: ORIRO
+disable-model-invocation: true
+name: health-skin
+provider: ORIRO.ai
+copyright: Copyright (c) 2026 ORIRO.ai
+description: >
+  Skin health and dermatology — skin care, common conditions, sun protection,
+  acne, eczema, psoriasis, and skin cancer prevention. Activate for questions
+  about skin care, rashes, acne, skin conditions, sun protection, or any
+  skin health question. Sources: AAD (American Academy of Dermatology), NIH.
+---
+
+# Skin Health and Dermatology
+
+## Skin basics
+
+**Three layers:** Epidermis (outer, barrier), Dermis (collagen, blood vessels, hair follicles, glands), Subcutis/Hypodermis (fat, insulation).
+**Skin functions:** Barrier (infection, UV), temperature regulation, sensation, vitamin D synthesis.
+**Skin types:** Normal, dry, oily, combination, sensitive. Can change with age, climate, products.
+
+## Sun protection (most important anti-aging and cancer prevention)
+
+**UV radiation:** UVA (ages skin, penetrates glass) + UVB (burns, main cause of skin cancer).
+**SPF:** Measures UVB protection only. SPF 30 blocks 97%. SPF 50 blocks 98%. Diminishing returns above 50.
+**Broad spectrum:** Protects against both UVA and UVB. Required on the label.
+**Application:** 1 ounce (shot glass) for full body. Reapply every 2 hours in sun, after swimming/sweating.
+**Daily use:** On face even without direct sun exposure. UVA penetrates windows.
+**Melanoma:** Most dangerous skin cancer. ABCDEs: Asymmetry, Border irregularity, multiple Colors, Diameter > 6mm, Evolving. Any changing mole → dermatologist.
+
+## Common skin conditions
+
+### Acne
+
+**Pathophysiology:** Excess sebum + C. acnes bacteria + clogged pores + inflammation.
+**Treatment ladder:**
+Mild: Benzoyl peroxide (kills bacteria) or salicylic acid (exfoliates) — OTC.
+Moderate: Topical retinoids (tretinoin) + topical antibiotics — prescription.
+Severe: Oral antibiotics + topical retinoids, or isotretinoin (Accutane) for severe nodular/cystic.
+**Retinoids:** Most evidence for acne AND anti-aging. Start slowly (every other night), expect initial irritation. Results in 3-6 months.
+
+### Eczema (Atopic Dermatitis)
+
+Chronic inflammatory skin condition. Itchy, red, dry patches. Often begins in childhood.
+**Management:** Moisturize frequently (thick creams, not lotions). Avoid triggers (soaps, certain fabrics, temperature extremes). Topical corticosteroids for flares. Dupilumab (Dupixent) biologic for moderate-severe.
+
+### Psoriasis
+
+Autoimmune. Rapid skin cell turnover → thick plaques with silvery scales. Elbows, knees, scalp common.
+Can be associated with psoriatic arthritis.
+Treatment: Topical corticosteroids, vitamin D analogues, systemic biologics for severe (TNF inhibitors, IL-17, IL-23 inhibitors).
+
+## Skincare routine (evidence-based)
+
+**Morning:**
+
+1. Gentle cleanser (if needed — many people only need water in AM)
+2. Vitamin C serum (antioxidant, brightening)
+3. Moisturizer
+4. SPF 30+ broad spectrum
+
+**Evening:**
+
+1. Cleanser (double-cleanse if wore SPF)
+2. Retinol/retinoid (anti-aging, acne)
+3. Moisturizer
+
+**Don't need:** Most of what advertising says you need. Fewer products with proven ingredients beat elaborate routines with trendy ones.
+Proven ingredients: SPF (prevent), Retinoids (treat aging, acne), Vitamin C (antioxidant), Niacinamide (multiple benefits), Hyaluronic acid (hydration), Ceramides (barrier repair).
+
+Sources: AAD (aad.org — free patient education), Skincare by Hyram evidence-based content (free), r/SkincareAddiction wiki (community-curated free resource)

package/skills/health/health-sleep/LICENSE

@@ -1,21 +1,21 @@
-MIT License
-
-Copyright (c) 2026 ORIRO.ai
-
-Permission is hereby granted, free of charge, to any person obtaining a copy
-of this software and associated documentation files (the "Software"), to deal
-in the Software without restriction, including without limitation the rights
-to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
-copies of the Software, and to permit persons to whom the Software is
-furnished to do so, subject to the following conditions:
-
-The above copyright notice and this permission notice shall be included in all
-copies or substantial portions of the Software.
-
-THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
-IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
-FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
-AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
-LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
-OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
-SOFTWARE.
+MIT License
+
+Copyright (c) 2026 ORIRO.ai
+
+Permission is hereby granted, free of charge, to any person obtaining a copy
+of this software and associated documentation files (the "Software"), to deal
+in the Software without restriction, including without limitation the rights
+to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
+copies of the Software, and to permit persons to whom the Software is
+furnished to do so, subject to the following conditions:
+
+The above copyright notice and this permission notice shall be included in all
+copies or substantial portions of the Software.
+
+THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
+IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
+FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
+AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
+LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
+OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
+SOFTWARE.

package/skills/health/health-sleep/SKILL.md

@@ -1,81 +1,81 @@
----
-watermark: ORIRO
-disable-model-invocation: true
-name: health-sleep
-provider: ORIRO.ai
-copyright: Copyright (c) 2026 ORIRO.ai
-description: >
-  Sleep science and sleep disorders — sleep architecture, insomnia, sleep apnea,
-  sleep hygiene, and evidence-based sleep improvement. Activate for questions
-  about sleep problems, insomnia, sleep hygiene, feeling tired, or any sleep
-  question. Sources: AASM, NIH sleep research, Matthew Walker sleep science.
----
-
-# Sleep Science
-
-## Sleep architecture
-
-Sleep cycles last ~90 minutes. 4-6 cycles per night.
-**NREM Stage 1 (5%):** Light sleep. Easy to wake.
-**NREM Stage 2 (45%):** Temperature drops, heart rate slows. Memory consolidation begins. Sleep spindles.
-**NREM Stage 3/SWS (25%):** Deep sleep. Growth hormone release. Physical restoration. Hardest to wake. Most restorative for body.
-**REM (25%):** Rapid Eye Movement. Dreaming. Emotional processing. Memory consolidation. Brain activity near-waking levels.
-
-**Sleep pressure and circadian rhythm:** Two processes regulate sleep timing.
-Adenosine builds during waking (sleep pressure — caffeine blocks adenosine).
-Circadian clock driven by light exposure controls alertness cycle.
-Both must align for optimal sleep.
-
-## How much sleep you need
-
-Adults: 7-9 hours (most need 8; few genuinely function on 6).
-Teens: 8-10 hours. Children 6-12: 9-12 hours.
-**You cannot sleep train yourself to need less.** People who claim to function on 5-6 hours are typically impaired and unaware of it (studies show self-reported vs. objective performance diverge dramatically).
-
-## Sleep hygiene — evidence-based practices
-
-### The environment
-
-**Cool room:** 65-68°F (18-20°C). Body must drop core temperature to initiate sleep.
-**Dark:** Blackout curtains or sleep mask. Light at 10 lux (dim room light) delays melatonin by 1.5 hours.
-**Quiet:** White noise if needed.
-
-### Timing and habits
-
-**Fixed wake time:** Wake the same time every day (including weekends). Most important sleep hygiene factor. Anchors your circadian rhythm.
-**No caffeine after 2pm:** Caffeine has ~5-7 hour half-life. Afternoon coffee stays in your system.
-**Limit alcohol:** Alcohol causes sedation but disrupts REM sleep. Net sleep quality loss.
-**No screens 30-60 min before bed:** Blue light delays melatonin. Even if device has "night mode" — the stimulation itself matters.
-**Wind-down routine:** Same pre-sleep sequence. Signals brain that sleep is coming.
-**Don't lie in bed awake:** If awake >20 minutes, get up, do something quiet in dim light, return when sleepy. Prevents bed becoming associated with wakefulness.
-
-## Insomnia
-
-**Defined:** Difficulty falling asleep or staying asleep ≥3 nights/week for ≥3 months, causing daytime impairment.
-**Prevalence:** ~10% chronic insomnia; 30-35% experience occasional insomnia.
-
-**CBT-I (Cognitive Behavioral Therapy for Insomnia):** First-line treatment. More effective than sleeping pills long-term.
-Core components: Sleep restriction (initially limit time in bed), stimulus control (bed only for sleep/sex), relaxation training, cognitive restructuring.
-**Sleeping pills:** Short-term use only. Benzodiazepines and Z-drugs cause rebound insomnia. Don't address root causes.
-
-## Sleep apnea
-
-**Obstructive Sleep Apnea (OSA):** Upper airway collapses repeatedly during sleep.
-**Signs:** Loud snoring, gasping/choking, witnessed breathing pauses, excessive daytime sleepiness, morning headaches, partner complaints.
-**Risk factors:** Obesity, male sex, age, neck size, craniofacial anatomy.
-**Diagnosis:** Sleep study (polysomnography — in lab or home sleep test).
-**Treatment:** CPAP (continuous positive airway pressure) — highly effective. Oral appliances for mild-moderate. Weight loss. Positional therapy.
-Untreated OSA: Hypertension, cardiovascular disease, diabetes, cognitive impairment.
-
-## Shift work and jet lag
-
-**Jet lag:** Cross 2+ time zones. Body clock lags behind local time.
-Eastward travel (losing time) harder than westward.
-Recovery: ~1 day per time zone.
-Melatonin: 0.5-3mg at local bedtime helps reset. Timing matters more than dose.
-
-**Shift work:** Chronic misalignment between circadian clock and work schedule.
-Associated with: Metabolic syndrome, cardiovascular disease, cancer, depression.
-Strategies: Strategic light exposure, blackout sleep environment, melatonin, consistency in schedule.
-
-Sources: AASM (aasm.org — free patient resources), NIH sleep research summaries (sleepfoundation.org), Matthew Walker "Why We Sleep" (principles), CBTI Coach app (VA-developed, free)
+---
+watermark: ORIRO
+disable-model-invocation: true
+name: health-sleep
+provider: ORIRO.ai
+copyright: Copyright (c) 2026 ORIRO.ai
+description: >
+  Sleep science and sleep disorders — sleep architecture, insomnia, sleep apnea,
+  sleep hygiene, and evidence-based sleep improvement. Activate for questions
+  about sleep problems, insomnia, sleep hygiene, feeling tired, or any sleep
+  question. Sources: AASM, NIH sleep research, Matthew Walker sleep science.
+---
+
+# Sleep Science
+
+## Sleep architecture
+
+Sleep cycles last ~90 minutes. 4-6 cycles per night.
+**NREM Stage 1 (5%):** Light sleep. Easy to wake.
+**NREM Stage 2 (45%):** Temperature drops, heart rate slows. Memory consolidation begins. Sleep spindles.
+**NREM Stage 3/SWS (25%):** Deep sleep. Growth hormone release. Physical restoration. Hardest to wake. Most restorative for body.
+**REM (25%):** Rapid Eye Movement. Dreaming. Emotional processing. Memory consolidation. Brain activity near-waking levels.
+
+**Sleep pressure and circadian rhythm:** Two processes regulate sleep timing.
+Adenosine builds during waking (sleep pressure — caffeine blocks adenosine).
+Circadian clock driven by light exposure controls alertness cycle.
+Both must align for optimal sleep.
+
+## How much sleep you need
+
+Adults: 7-9 hours (most need 8; few genuinely function on 6).
+Teens: 8-10 hours. Children 6-12: 9-12 hours.
+**You cannot sleep train yourself to need less.** People who claim to function on 5-6 hours are typically impaired and unaware of it (studies show self-reported vs. objective performance diverge dramatically).
+
+## Sleep hygiene — evidence-based practices
+
+### The environment
+
+**Cool room:** 65-68°F (18-20°C). Body must drop core temperature to initiate sleep.
+**Dark:** Blackout curtains or sleep mask. Light at 10 lux (dim room light) delays melatonin by 1.5 hours.
+**Quiet:** White noise if needed.
+
+### Timing and habits
+
+**Fixed wake time:** Wake the same time every day (including weekends). Most important sleep hygiene factor. Anchors your circadian rhythm.
+**No caffeine after 2pm:** Caffeine has ~5-7 hour half-life. Afternoon coffee stays in your system.
+**Limit alcohol:** Alcohol causes sedation but disrupts REM sleep. Net sleep quality loss.
+**No screens 30-60 min before bed:** Blue light delays melatonin. Even if device has "night mode" — the stimulation itself matters.
+**Wind-down routine:** Same pre-sleep sequence. Signals brain that sleep is coming.
+**Don't lie in bed awake:** If awake >20 minutes, get up, do something quiet in dim light, return when sleepy. Prevents bed becoming associated with wakefulness.
+
+## Insomnia
+
+**Defined:** Difficulty falling asleep or staying asleep ≥3 nights/week for ≥3 months, causing daytime impairment.
+**Prevalence:** ~10% chronic insomnia; 30-35% experience occasional insomnia.
+
+**CBT-I (Cognitive Behavioral Therapy for Insomnia):** First-line treatment. More effective than sleeping pills long-term.
+Core components: Sleep restriction (initially limit time in bed), stimulus control (bed only for sleep/sex), relaxation training, cognitive restructuring.
+**Sleeping pills:** Short-term use only. Benzodiazepines and Z-drugs cause rebound insomnia. Don't address root causes.
+
+## Sleep apnea
+
+**Obstructive Sleep Apnea (OSA):** Upper airway collapses repeatedly during sleep.
+**Signs:** Loud snoring, gasping/choking, witnessed breathing pauses, excessive daytime sleepiness, morning headaches, partner complaints.
+**Risk factors:** Obesity, male sex, age, neck size, craniofacial anatomy.
+**Diagnosis:** Sleep study (polysomnography — in lab or home sleep test).
+**Treatment:** CPAP (continuous positive airway pressure) — highly effective. Oral appliances for mild-moderate. Weight loss. Positional therapy.
+Untreated OSA: Hypertension, cardiovascular disease, diabetes, cognitive impairment.
+
+## Shift work and jet lag
+
+**Jet lag:** Cross 2+ time zones. Body clock lags behind local time.
+Eastward travel (losing time) harder than westward.
+Recovery: ~1 day per time zone.
+Melatonin: 0.5-3mg at local bedtime helps reset. Timing matters more than dose.
+
+**Shift work:** Chronic misalignment between circadian clock and work schedule.
+Associated with: Metabolic syndrome, cardiovascular disease, cancer, depression.
+Strategies: Strategic light exposure, blackout sleep environment, melatonin, consistency in schedule.
+
+Sources: AASM (aasm.org — free patient resources), NIH sleep research summaries (sleepfoundation.org), Matthew Walker "Why We Sleep" (principles), CBTI Coach app (VA-developed, free)

package/skills/health/health-womens/LICENSE

@@ -1,21 +1,21 @@
-MIT License
-
-Copyright (c) 2026 ORIRO.ai
-
-Permission is hereby granted, free of charge, to any person obtaining a copy
-of this software and associated documentation files (the "Software"), to deal
-in the Software without restriction, including without limitation the rights
-to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
-copies of the Software, and to permit persons to whom the Software is
-furnished to do so, subject to the following conditions:
-
-The above copyright notice and this permission notice shall be included in all
-copies or substantial portions of the Software.
-
-THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
-IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
-FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
-AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
-LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
-OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
-SOFTWARE.
+MIT License
+
+Copyright (c) 2026 ORIRO.ai
+
+Permission is hereby granted, free of charge, to any person obtaining a copy
+of this software and associated documentation files (the "Software"), to deal
+in the Software without restriction, including without limitation the rights
+to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
+copies of the Software, and to permit persons to whom the Software is
+furnished to do so, subject to the following conditions:
+
+The above copyright notice and this permission notice shall be included in all
+copies or substantial portions of the Software.
+
+THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
+IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
+FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
+AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
+LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
+OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
+SOFTWARE.

package/skills/health/health-womens/SKILL.md

@@ -1,72 +1,72 @@
----
-watermark: ORIRO
-disable-model-invocation: true
-name: health-womens
-provider: ORIRO.ai
-copyright: Copyright (c) 2026 ORIRO.ai
-description: >
-  Women's health — reproductive health, hormones, menstrual health, menopause,
-  breast health, contraception, and women-specific health concerns. Activate
-  for questions about periods, contraception, fertility, PCOS, endometriosis,
-  menopause, or any women's health question. Sources: ACOG, NWHN, CDC women's health.
----
-
-# Women's Health
-
-## Menstrual health
-
-**Normal cycle:** 21-35 days. Duration 2-7 days. Blood loss 20-80 mL. Some cramping normal.
-**Dysmenorrhea (painful periods):** Primary (no underlying cause) or secondary (endometriosis, fibroids).
-Treatment: NSAIDs (start 1-2 days before onset), hormonal contraception, heat therapy.
-
-**When to see a doctor:**
-
-- Cycles < 21 or > 35 days consistently
-- Bleeding > 7 days or soaking a pad/tampon every 1-2 hours
-- Severe cramping disrupting daily life
-- Spotting between periods (especially post-menopause)
-- Significant recent changes in cycle
-
-**PCOS (Polycystic Ovary Syndrome):** Most common endocrine disorder in reproductive-age women. Irregular cycles, excess androgens (acne, hair loss, facial hair), ovarian cysts. Management: Lifestyle (exercise, nutrition), hormonal contraception, metformin for metabolic features, spironolactone for androgen effects.
-
-**Endometriosis:** Uterine tissue growing outside uterus. Severe painful periods, pain with sex, infertility. Often delayed diagnosis (7-10 years average). Treatment: Pain management, hormonal therapy, surgery.
-
-## Contraception options
-
-**Hormonal:**
-Combination pill (estrogen + progestin): 91% effective (typical use), 99.7% (perfect). Daily pill. Also regulates periods, reduces cramps, improves acne.
-Progestin-only pill (mini-pill): For those who can't tolerate estrogen. Must take at same time daily.
-Patch (Xulane): Weekly. Same hormones as combined pill.
-Ring (NuvaRing): Monthly vaginal ring. Convenient.
-Injectable (Depo-Provera): Every 3 months. May cause irregular bleeding or amenorrhea.
-Implant (Nexplanon): 3-year arm implant. 99.9% effective. Most effective reversible option. Can cause irregular bleeding.
-Hormonal IUD (Mirena, Liletta, Kyleena, Skyla): 3-8 years. 99.9% effective. Reduces bleeding significantly.
-
-**Non-hormonal:**
-Copper IUD (Paragard): 10+ years. 99.9% effective. May increase cramping/bleeding. Also emergency contraception within 5 days.
-Condoms: 85% effective (typical use), 98% (perfect). Only method preventing STIs.
-Diaphragm/cap with spermicide: Requires fitting, insertion before sex. Less effective (88% typical use).
-
-**Emergency contraception:**
-Plan B/levonorgestrel: Within 72 hours (less effective 72-120 hours). 89% effective.
-Ella (ulipristal acetate): Within 120 hours. More effective than levonorgestrel, especially near ovulation.
-Copper IUD: Within 120 hours. Most effective (> 99%).
-
-## Breast health
-
-**Self-exam:** Know your normal. Report changes (lumps, skin changes, nipple discharge, pain).
-**Mammogram guidelines (USPSTF 2024):** Begin at age 40 for average-risk women. Every 2 years.
-Higher-risk women (BRCA mutation, strong family history): Earlier and more frequent screening + MRI. Discuss with doctor.
-
-**Dense breast tissue:** Common (40% of women). More mammograms needed. Supplemental ultrasound or MRI often recommended.
-
-## Menopause
-
-**Average age:** 51 (range 45-55). Defined as 12 months without period.
-**Perimenopause:** Transition period (2-10 years). Irregular cycles, hot flashes may begin.
-**Symptoms:** Hot flashes, night sweats, vaginal dryness, sleep disruption, mood changes, cognitive symptoms, joint pain, decreased libido.
-**Menopause Hormone Therapy (MHT/HRT):** Most effective treatment for vasomotor symptoms.
-Current evidence: Initiated before age 60 or within 10 years of menopause = favorable risk/benefit. Benefits: Symptom relief, bone protection, may reduce cardiovascular risk when started early. Risks: Slight increase in breast cancer risk with combined estrogen+progestin (not estrogen alone for hysterectomy patients).
-**Non-hormonal options:** SSRIs/SNRIs (off-label, reduce hot flashes), gabapentin, clonidine, cognitive behavioral therapy.
-
-Sources: ACOG (acog.org — free patient education), NWHN (nwhn.org — free), CDC women's health (cdc.gov/women — free), Menopause Society (menopause.org — free patient resources)
+---
+watermark: ORIRO
+disable-model-invocation: true
+name: health-womens
+provider: ORIRO.ai
+copyright: Copyright (c) 2026 ORIRO.ai
+description: >
+  Women's health — reproductive health, hormones, menstrual health, menopause,
+  breast health, contraception, and women-specific health concerns. Activate
+  for questions about periods, contraception, fertility, PCOS, endometriosis,
+  menopause, or any women's health question. Sources: ACOG, NWHN, CDC women's health.
+---
+
+# Women's Health
+
+## Menstrual health
+
+**Normal cycle:** 21-35 days. Duration 2-7 days. Blood loss 20-80 mL. Some cramping normal.
+**Dysmenorrhea (painful periods):** Primary (no underlying cause) or secondary (endometriosis, fibroids).
+Treatment: NSAIDs (start 1-2 days before onset), hormonal contraception, heat therapy.
+
+**When to see a doctor:**
+
+- Cycles < 21 or > 35 days consistently
+- Bleeding > 7 days or soaking a pad/tampon every 1-2 hours
+- Severe cramping disrupting daily life
+- Spotting between periods (especially post-menopause)
+- Significant recent changes in cycle
+
+**PCOS (Polycystic Ovary Syndrome):** Most common endocrine disorder in reproductive-age women. Irregular cycles, excess androgens (acne, hair loss, facial hair), ovarian cysts. Management: Lifestyle (exercise, nutrition), hormonal contraception, metformin for metabolic features, spironolactone for androgen effects.
+
+**Endometriosis:** Uterine tissue growing outside uterus. Severe painful periods, pain with sex, infertility. Often delayed diagnosis (7-10 years average). Treatment: Pain management, hormonal therapy, surgery.
+
+## Contraception options
+
+**Hormonal:**
+Combination pill (estrogen + progestin): 91% effective (typical use), 99.7% (perfect). Daily pill. Also regulates periods, reduces cramps, improves acne.
+Progestin-only pill (mini-pill): For those who can't tolerate estrogen. Must take at same time daily.
+Patch (Xulane): Weekly. Same hormones as combined pill.
+Ring (NuvaRing): Monthly vaginal ring. Convenient.
+Injectable (Depo-Provera): Every 3 months. May cause irregular bleeding or amenorrhea.
+Implant (Nexplanon): 3-year arm implant. 99.9% effective. Most effective reversible option. Can cause irregular bleeding.
+Hormonal IUD (Mirena, Liletta, Kyleena, Skyla): 3-8 years. 99.9% effective. Reduces bleeding significantly.
+
+**Non-hormonal:**
+Copper IUD (Paragard): 10+ years. 99.9% effective. May increase cramping/bleeding. Also emergency contraception within 5 days.
+Condoms: 85% effective (typical use), 98% (perfect). Only method preventing STIs.
+Diaphragm/cap with spermicide: Requires fitting, insertion before sex. Less effective (88% typical use).
+
+**Emergency contraception:**
+Plan B/levonorgestrel: Within 72 hours (less effective 72-120 hours). 89% effective.
+Ella (ulipristal acetate): Within 120 hours. More effective than levonorgestrel, especially near ovulation.
+Copper IUD: Within 120 hours. Most effective (> 99%).
+
+## Breast health
+
+**Self-exam:** Know your normal. Report changes (lumps, skin changes, nipple discharge, pain).
+**Mammogram guidelines (USPSTF 2024):** Begin at age 40 for average-risk women. Every 2 years.
+Higher-risk women (BRCA mutation, strong family history): Earlier and more frequent screening + MRI. Discuss with doctor.
+
+**Dense breast tissue:** Common (40% of women). More mammograms needed. Supplemental ultrasound or MRI often recommended.
+
+## Menopause
+
+**Average age:** 51 (range 45-55). Defined as 12 months without period.
+**Perimenopause:** Transition period (2-10 years). Irregular cycles, hot flashes may begin.
+**Symptoms:** Hot flashes, night sweats, vaginal dryness, sleep disruption, mood changes, cognitive symptoms, joint pain, decreased libido.
+**Menopause Hormone Therapy (MHT/HRT):** Most effective treatment for vasomotor symptoms.
+Current evidence: Initiated before age 60 or within 10 years of menopause = favorable risk/benefit. Benefits: Symptom relief, bone protection, may reduce cardiovascular risk when started early. Risks: Slight increase in breast cancer risk with combined estrogen+progestin (not estrogen alone for hysterectomy patients).
+**Non-hormonal options:** SSRIs/SNRIs (off-label, reduce hot flashes), gabapentin, clonidine, cognitive behavioral therapy.
+
+Sources: ACOG (acog.org — free patient education), NWHN (nwhn.org — free), CDC women's health (cdc.gov/women — free), Menopause Society (menopause.org — free patient resources)

package/skills/health/health-yoga-wellness/LICENSE

@@ -1,21 +1,21 @@
-MIT License
-
-Copyright (c) 2026 ORIRO.ai
-
-Permission is hereby granted, free of charge, to any person obtaining a copy
-of this software and associated documentation files (the "Software"), to deal
-in the Software without restriction, including without limitation the rights
-to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
-copies of the Software, and to permit persons to whom the Software is
-furnished to do so, subject to the following conditions:
-
-The above copyright notice and this permission notice shall be included in all
-copies or substantial portions of the Software.
-
-THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
-IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
-FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
-AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
-LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
-OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
-SOFTWARE.
+MIT License
+
+Copyright (c) 2026 ORIRO.ai
+
+Permission is hereby granted, free of charge, to any person obtaining a copy
+of this software and associated documentation files (the "Software"), to deal
+in the Software without restriction, including without limitation the rights
+to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
+copies of the Software, and to permit persons to whom the Software is
+furnished to do so, subject to the following conditions:
+
+The above copyright notice and this permission notice shall be included in all
+copies or substantial portions of the Software.
+
+THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
+IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
+FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
+AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
+LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
+OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
+SOFTWARE.